Self-Monitoring Blood Glucose Devices MarketProvides Information on the Historical and Current Market Size and the Future Potential of the Market

Global self-monitoring blood glucose devices market size is forecasted to reach $18.6 billion by 2023, according to P&S Market Research.
This growth in the market is attributed to the increasing prevalence of diabetes, surge in geriatric population, and technological advancements. Moreover, increasing awareness about diabetic care, rising obese population, and favorable in health insurance and reimbursement scenario are also driving the growth of the market, globally.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market

Self-monitoring blood glucose devices are mainly used for monitoring type 1 and type 2 diabetes. Between the two, the use of self-monitoring blood glucose devices is expected to exhibit faster growth for monitoring type 2 diabetes, with a CAGR of 6.0% during the forecast period. This is attributed to the rising prevalence of type 2 diabetes among adults, which is substantiated from the fact that, among all diabetes cases, 90% to 95% of the cases are found to be suspected with type 2.

Some of the risk factors of type 2 diabetes include increasing geriatric population, family history of diabetes, impaired glucose tolerance, and obesity and physical inactivity. Moreover, ethnicity is also a risk factor for the occurrence of type 2 diabetes. African Americans, American Indians, Hispanic/Latino Americans, and some Asian Americans and Pacific Islanders have high probability of developing type 2 diabetes.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market/report-sample

In addition, rising awareness about diabetes and its complications such as, delayed wound healing and diabetic foot ulcer) is also accelerating the growth of self-monitoring blood glucose devices market in the region. For instance, in October 2018, IDF has announced to organize an event titled as “IDF Diabetes Complications and Foot Congress 2018”, in Hyderabad, India. The event would provide information diabetes and complications associated with it, along with its management.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=self-monitoring-blood-glucose-market

Key players are launching various products in the self-monitoring blood glucose devices industry to increase their market share. For instance, in August 2017, Nova Biomedical launched the CE-Marked critical care analyzer, Stat Profile Prime Plus, for improving the testing standards. It provides 22 essential critical care tests that include blood gases, electrolytes, metabolites, hematology, and co-oximetry. Prime Plus also features new and patented, non-lysing whole blood co-oximetry technology, along with automated quality control (QC), powerful data management, bidirectional connectivity, and extensive cybersecurity protection.

Some of the other key players (other than those mentioned above) operating in the self-monitoring blood glucose devices market are Johnson & Johnson, Sinocare Inc., ARKRAY Inc., Medtronic plc, B. Braun Melsungen AG, Abbott Laboratories, and Bayer AG.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.